Meningitis Outbreak Tied to Framingham Massachusetts Pharmacy

October 7, 2012
By Parker Scheer LLP on October 7, 2012 10:40 AM |

iStock_000020900352_ExtraSmall.jpgA total of 52 people have now been identified as being infected with fungal meningitis after receiving injectable steroids (methylprednisolone acetate) prepared by New England Compounding Center Inc. in Framingham, Massachusetts. The newest count brings to eight, the number of states reporting infections tied to the tainted medications, which has already claimed five lives.

To date, more than 950 people have been identified as receiving the tainted medication from the Framingham pharmacy. Those infected reported symptoms including headache and fever, and traces of meningitis were found in the patient's spinal fluid. Meningitis, which can be either viral or bacterial in nature, is an inflammation of the membranes covering the brain ("meninges") and can be fatal. A list of health care facilities and dispensaries believed to have received tainted lots can be found at http://www.cdc.gov/HAI/outbreaks/meningitis.html

Parker Scheer LLP is closely following the ongoing investigation of the Framingham, Massachusetts pharmacy. If you or someone you know has suffered an infection thought to be caused by tainted medication, call us. There is never a charge to discuss your potential case and all information shared will be maintained in strict confidence. Parker Scheer attorneys are available to speak with you seven (7) days at 866-414-0400.